New Agents Changing Management of Advanced Prostate Cancer

Share this content:

New therapeutic agents are changing how patients with advanced prostate cancer are managed. John Schieszer reports in today's Medical Minute that denosumab along with immunotherapy may help make advanced prostate cancer become more of a chronic illness than a terminal disease.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters